Aspirin may not provide benefits for type 2 diabetes patients

04/29/2013 | DailyRx.com

Type 2 diabetes patients with no previous cardiovascular disease who were on low-dose aspirin treatment did not show a lower risk of cardiovascular disease or death at 3.9 years compared with nonusers, according to a study in BMJ Open. Researchers noted a slightly increased risk of both fatal and non-fatal heart disease in female aspirin users compared with women who did not take the drug.

View Full Article in:

DailyRx.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC